Sunday, July 12, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “inhibitor”

2,878 pharma patents match "inhibitor" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,878
Index total 30,257
Page 57 / 120

Quick answer

This filtered view shows 2,878 pharmaceutical patents matching "inhibitor" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,878 results for “inhibitor” · 30,257 patents in full index Clear search

  1. US 9783586

    Inhibitors of the linear ubiquitin chain assembly complex (LUBAC) and related methods

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  2. US 9783550

    Highly potent inhibitors of porcupine

    The Board of Regents of the University of Texas System · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  3. US 9783507

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  4. US 9782398

    Pharmaceutical compositions comprising an antipsychotic drug and a VMAT2 inhibitor and uses thereof

    Neurocrine Biosciences, Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  5. US 9783572

    Synthesis of syrbactin proteasome inhibitors

    The Regents of the University of California · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  6. US 9775876

    Compositions and methods for CaMKII inhibitors and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted

  7. US 9777024

    Heteroaryl inhibitors of PDE4

    Tetra Discovery Partners · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted

  8. US 9771585

    miR-155 inhibitors for treating cutaneous T cell lymphoma (CTCL)

    MIRAGEN THERAPEUTICS, INC. · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

  9. US 9771361

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

  10. US 9771337

    Neprilysin inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

  11. US 9771366

    Substituted tetrahydropyrido[3′,2′:4,5]pyrrolo[1,2-a]pyrazine-2-carboxamides as RSK inhibitors

    PHOENIX MOLECULAR DESIGNS · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted

  12. US 9765055

    Intramolecular hydrogen-bonded nitric oxide synthase inhibitors

    Northwestern University · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  13. US 9765099

    STAT6 inhibitors

    The Board of Regents of the University of Texas System · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  14. US 9765066

    Selective HDAC1 and HDAC2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted

  15. US 9757382

    Quinazolines and azaquinazolines as dual inhibitors of RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways

    Asana BioSciences, LLC · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted

  16. US 9750748

    Pyridazinones as DAAO enzyme inhibitors

    Takeda Pharmaceutical Company Limited · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted

  17. US 9752143

    Locked nucleic acid inhibitor of miR-145 and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted

  18. US 9750724

    Use of an aromatase inhibitor for the treatment of hypogonadism and related diseases

    MEREO BIOPHARMA 2 LIMITED · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted

  19. US 9750717

    Inhibitors of CD40-TRAF6 interaction

    Ludwig-Maximilians-Universitat Munchen · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted

  20. US 9752144

    Inhibitors of MYH7B and uses thereof

    MIRAGEN THERAPEUTICS, INC. · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted

  21. US 9745314

    MDM2 inhibitors and therapeutic methods using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted

  22. US 9745255

    Meta-substituted biphenyl peripherally restricted FAAH inhibitors

    The Regents of the University of California · Granted Aug 29, 2017 · Expires Aug 24, 2037

    granted

  23. US 9738641

    Bicyclic inhibitors

    KalVista Pharmaceuticals Limited · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted

  24. US 9738629

    Bridged ring compounds as Hepatitis C virus inhibitors, pharmaceutical compositions and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 22, 2017 · Expires Aug 17, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.